A bench of Chief Justice G Rohini and Justice Sangita Dhingra Sehgal refused to pass an interim order staying the launch of the medicine, but said any such action taken would be subject to further order of the court.
With the direction, the bench listed the matter for hearing on August 31.
The petition has questioned the approval given to Indian drug company Gennova Biopharmaceuticals Ltd with regard to its biosimilar drug of Tenecteplase which is used for treating stroke patients.
He has sought revocation of the recommendations in favour of the biosimilar drug as well as the marketing approval granted to it.
His petition also seeks directions restraining the company from launching the medicine and if launched, a declaration ot the effect that it was done illegally.
According to the prosecution, a secret information was
received on July 7, 2005 that Sharafat, suspected to trade in narcotics with his gang members in Delhi on a large scale, was to come to his residence.
Delhi Police had said that since it was alleged that Sharafat was the chief of a crime syndicate and was amassing wealth through illegal trade of narcotics, provisions under MCOCA were invoked.
Later sanction was granted by the Additional Commissioner of Police for prosecution of Sharafat and other accused -- Mohd Saleem, Sheikh Hannan, and Najma Sheikh (first wife of Sharafat) and subsequently, the first charge sheet was filed on December 10, 2005.
She had later applied for regular bail and it was dismissed by the sessions court last year, after which she moved the high court.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
